Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
出版年份 2021 全文链接
标题
Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
作者
关键词
Rheumatic diseases, COVID-19, Outcomes, SARS-CoV-2
出版物
AUTOIMMUNITY REVIEWS
Volume -, Issue -, Pages 102778
出版商
Elsevier BV
发表日期
2021-02-21
DOI
10.1016/j.autrev.2021.102778
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Responding to Covid-19 — A Once-in-a-Century Pandemic?
- (2020) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine
- (2020) Emanuele Bozzalla Cassione et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
- (2020) Cong Ye et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
- (2020) Sara Monti et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- (2020) Federica Raucci et al. AUTOIMMUNITY REVIEWS
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- COVID-19 with rheumatic diseases: a report of 5 cases
- (2020) Chuanfang Cheng et al. CLINICAL RHEUMATOLOGY
- Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy
- (2020) Luca Quartuccio et al. JOINT BONE SPINE
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phylogenetic network analysis of SARS-CoV-2 genomes
- (2020) Peter Forster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19 in Rheumatic Disease Patients on Immunosuppressive Agents
- (2020) Saika Sharmeen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs
- (2020) Khalil Ansarin et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine
- (2020) Cheng Lay Teh et al. ANNALS OF THE RHEUMATIC DISEASES
- Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
- (2020) Maurizio Benucci et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study
- (2020) Yao Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia
- (2020) Sharifah Aishah Wan et al. ANNALS OF THE RHEUMATIC DISEASES
- No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)
- (2020) Peer Aries et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
- (2020) Dalifer D Freites Nuñez et al. ANNALS OF THE RHEUMATIC DISEASES
- Implications of SARS-CoV-2 infection for patients with rheumatic disease
- (2020) Changsong Lin et al. ANNALS OF THE RHEUMATIC DISEASES
- Covid-19 and autoimmunity
- (2020) Michael Ehrenfeld et al. AUTOIMMUNITY REVIEWS
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
- (2020) C. Sieiro Santos et al. CLINICAL RHEUMATOLOGY
- COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain
- (2020) Rubén Queiro Silva et al. Dermatologic Therapy
- No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
- (2020) Ho So et al. JOURNAL OF RHEUMATOLOGY
- Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
- (2020) Jesse Veenstra et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ethnic disparities in COVID-19 mortality: are comorbidities to blame?
- (2020) Krithi Ravi LANCET
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
- (2020) Xabier Michelena et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus
- (2020) Ruth Fernandez‐Ruiz et al. Arthritis & Rheumatology
- Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
- (2020) Ennio Giulio Favalli et al. Arthritis & Rheumatology
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2
- (2020) Ted R. Mikuls et al. Arthritis & Rheumatology
- COVID‐19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration
- (2020) Jiacai Cho et al. International Journal of Rheumatic Diseases
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
- (2015) Camille Roubille et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started